Tandem Diabetes (TNDM) Misses Q1 EPS by 8c, Revenues Beat; Provides 2Q Revenue Outlook, Withdraws FY20 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 17.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.65 | 52 Week High | $12.48 | |||
| Open | $17.65 | 52 Week Low | $1.60 | |||
| Day High | $17.65 | P/E | N/A | |||
| Day Low | $17.65 | EPS | $-6.33 | |||
| Volume | 3,370 | |||||
